Table 2.
Volunteer # | Blood Schizontocide | PQ dose | Hour on Day 0 |
Day Post-Therapy |
|||
---|---|---|---|---|---|---|---|
0 | 12 | 1 | 7 | 14 | |||
3 | 300 mg CQ | 0 | 70% | 60% | nd | 50% | 10% |
4 | 300 mg CQ | 0 | 60% | nd | 75% | 25% | nd |
6 | None | 45 mg | 60% | 80% | 10% | 0% | 0% |
7 | None | 45 mg | 70% | 65% | 0% | 0% | 15% |
8 | None | 45 mg | 65% | nd | 0% | 0% | 0% |
9 | None | 30 mg | 80% | 40% | 0% | 0% | nd |
10 | None | 30 mg | 75% | 40% | 0% | nd | nd |
11 | None | 30 mg | 80% | 75% | 10% | 0% | nd |
12 | None | 30 mg | nd | 35% | 0% | 20% | nd |
14 | None | 15 mg | 75% | 25% | 60% | 0% | nd |
15 | None | 15 mg | 30% | nd | 0% | 0% | nd |
16 | None | 15 mg | 75% | nd | 55% | 0% | nd |
17 | None | 15 mg | 65% | nd | 40% | 0% | 0% |
Adapted from Rieckmann et al, [22].
Nd: No data